| Value | ₹7.61 Cr |
|---|---|
| Execution period | April, 2026 |
NSE filing, NSE: SHADOWFAX. Summary written from the filing by ALFA Finder's alert engine.
Shadowfax Technologies Ltd: key numbers
- Share price
- ₹271.85
- Market cap
- ₹15,957 Cr
- Revenue (annual)
- ₹4,202 Cr
- Net profit (annual)
- ₹111.7 Cr
- P/E (TTM)
- 71.2×Sector 27.7×
- Promoter holding
- 16.46%-0.05% QoQ
- FII holding
- 16.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shadowfax Technologies Ltd
All →Shadowfax Technologies Earnings Call Transcript: Key Takeaways
Shadowfax hit record ₹1,538 Cr revenue and 5% EBITDA margin, signaling strong transition toward profitability.
Shadowfax Technologies Other Announcement
Shadowfax submitted CARE Ratings' monitoring agency report on IPO proceeds for the quarter ended September 30, 2026. The report shows no deviation from the offer objects.
Shadowfax Technologies Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹1,538 Cr (+56.6% YoY), PAT ₹68 Cr (4.4% margin), Adj. EBITDA ₹77 Cr (5.0% margin); speed-led share gains across Express, Hyperlocal and Prime D2C.
Shadowfax Technologies Results Update
Shadowfax reported Q2 FY27 revenue of ₹1,538 Cr, up 56.6% YoY, with PAT at ₹68 Cr. Sixth consecutive 55%+ growth quarter, Adj. EBITDA margin at 5.0%.
Shadowfax Technologies Q2 FY27 Results: Net Profit ₹68 Cr, Up 423.1% YoY
Shadowfax Technologies Ltd reported revenue from operations of ₹1,538 Cr (+56.6% YoY) and net profit of ₹68 Cr (+423.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹68 Cr · +423.1% YoY
Shadowfax Technologies Board Meeting Date
Shadowfax Technologies will hold a board meeting on 29 October 2026 to approve September 2026 quarter results. An earnings call follows the same day at 5 p.m.
Other acquisition announcements
All →Arvaya Healthcare Acquisition
Arvaya Healthcare completed the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited on 1 November 2026. The target is now a wholly-owned subsidiary, with no consideration amount disclosed.
Affle 3I Acquisition Worth ₹3,990 Cr
Affle 3i's step-down subsidiary will acquire Perion Network in an all-cash deal valued at about ₹3,990 Crore. Closing is expected in early 2027.
- Value
- ₹3,990 Cr
- Execution
- Expected to close in early 2027
Sai Parenterals Acquisition
Sai Parenterals will acquire the remaining 25% stake in its 75% subsidiary SP Analytics for cash, making it wholly owned. Related-party approval was taken at the 1 November 2026 board meeting, with completion by 31 December 2026.
- Execution
- 31-12-2026
R R Kabel Acquisition Worth ₹77 Cr
R R Kabel completed its acquisition of U M Cables' optical fibre business via slump sale for Rs.77 Crore. The transaction took effect from 31 October 2026.
- Value
- ₹77.00 Cr
R R Kabel Acquisition
R R Kabel completed its acquisition of U M Cables' business undertaking via slump sale, effective 31 October 2026. No consideration amount was disclosed in this intimation.
JSW Steel Acquisition
JSW Steel's scheme to amalgamate Piombino Steel became effective on 31 October 2026. Piombino now stands merged into JSW Steel under the NCLT-sanctioned scheme.